Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001516551-22-000040
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$3.13M | -$1.82M | -$1.30M | -$4.93M |
| EPS Diluted | -$1.58 | $0.00 | -$0.01 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Sep 30, 2022 · filed Nov 14, 2022 · 45 d after period end
